← Back
Countries

USA: Treatment options

Almost every modern type of leukaemia treatment is available in the USA: chemotherapy, targeted medicines, immunotherapy, CAR-T and transplant.

Last updated: ~1 min read
On a dark navy background, a branching path of light.
Figure 1.Paths — USA: Treatment options

01Short answer

Treatment is chosen by the type of leukaemia, genetics, age and general health, and is usually based on NCCN guidelines. FDA-approved targeted medicines (for example TKIs and FLT3, IDH and BCL-2 inhibitors), bispecific antibodies and CAR-T are widely used. Many centres also offer clinical trials as one of the options. Insurance coverage for each new treatment should be checked in advance.

02Simple explanation

Standard: per NCCN.

New medicines: FDA-approved.

Trials: one of the options.

03Scientific explanation

Medicines: NCI keeps a list of drugs approved for leukaemia.

Trials: ClinicalTrials.gov can be searched by state and centre.

04What happens in the body?

Standard treatment

Induction, consolidation, maintenance or long-term targeted treatment, depending on the type.

Cell therapy

CAR-T is approved in certain cases of B-ALL and is given at certified centres.

On a dark navy background, a cell with an antenna.
Figure 2.CAR-T — USA: Treatment options

Clinical trial

Check eligibility with your doctor; taking part is voluntary.

On a dark navy background, an index of cards.
Figure 3.Trials — USA: Treatment options

05Choosing treatment

Four steps.

Standard — Learn the recommendation.1StandardLearn the recommendation.
Target — Is there a genetic target?2TargetIs there a genetic target?
Trial — Check eligibility.3TrialCheck eligibility.
Plan — Decide together.4PlanDecide together.
ChoiceOptions are clear.
DirectionThe plan is agreed.

06Key points at a glance

TopicIn brief
Standard treatmentInduction, consolidation, maintenance or long-term targeted treatment, depending on the type.
Cell therapyCAR-T is approved in certain cases of B-ALL and is given at certified centres.
Clinical trialCheck eligibility with your doctor; taking part is voluntary.

07Key terms

Targeted therapy
Treatment aimed at a specific molecule.
CAR-T
Engineered T-cell therapy.
Clinical trial
A research study of treatment.
Off-label
Use outside the approved indication.

08Key points

  • Write down the treatment name.
  • Ask about alternatives.
  • Ask about trials.
  • Check insurance coverage.
  • Learn the side effects.

09Frequently asked questions

Are all new medicines available?

FDA-approved ones are, but access can vary by insurance and centre.

Must I join a trial?

No, it is entirely voluntary.

What is off-label use?

Using a medicine outside its official indication; your doctor decides based on evidence.

10Questions for your doctor

Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.

  1. Are all new medicines available?

  2. Must I join a trial?

  3. What is off-label use?

My questions

12Sources

  1. National Cancer Institute (NCI). Drugs Approved for Leukemia
  2. National Comprehensive Cancer Network (NCCN). NCCN Guidelines for Patients
  3. National Cancer Institute (NCI). CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers
  4. U.S. National Library of Medicine. ClinicalTrials.gov
  5. National Cancer Institute (NCI). Adult Acute Myeloid Leukemia Treatment (PDQ®) – Patient Version
  6. Cancer Research UK. Leukaemia
  7. Blood Cancer UK. Official website
  8. NHS. GP services
  9. NICE (National Institute for Health and Care Excellence). Official website
  10. GOV.UK. Medicines and Healthcare products Regulatory Agency
Medical disclaimerThis information is for educational purposes only and does not replace medical advice.
Last updated: ← Back to the list

Open the interactive site →